Top Markets
Coin of the day
Edesa Biotech, Inc. Edesa Biotech, Inc.

Edesa Biotech, Inc.

EDSA
株式のランク #25795
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering,... Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, and EB01, a topical therapy in a Phase 2B clinical study addressing chronic allergic contact dermatitis. Furthermore, Edesa has a licensing collaboration with NovImmune SA to advance monoclonal antibodies specifically designed to target TLR4 and CXCL10. This company was established in 2015 and is based in Markham, Canada.
株価
$4.80
時価総額
$46.24M
変化(1日)
-16.52%
変化(1年)
103.39%
CA
取引 Edesa Biotech, Inc. (EDSA)

カテゴリー

Edesa Biotech, Inc.(EDSA)の株価履歴
終値の最高値: $5.37 (2026-08-01)

終値の最安値: $602.70 (2010-06-01)
Edesa Biotech, Inc. の株価履歴(2010 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 188.73%
2025 -16.90%
2024 -58.03%
2023 -48.53%
2022 -77.76%
2021 16.75%
2020 12.06%
2019 -29.49%
2018 -84.76%
2017 -54.18%
2016 -73.20%
2015 -32.44%
2014 -36.36%
2013 592.43%
2012 -41.11%
2011 -62.20%
2010 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$539.14 36.71%
US
$1.04K 56.86%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$130.43 385.07%
US